NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of Palbociclib in Patients With Tumors Harboring Activating Alterations in Cell Cycle Genes
Phase of Trial: Phase II
Latest Information Update: 18 Feb 2019
At a glance
- Drugs Palbociclib (Primary)
- Indications CNS cancer; Non-Hodgkin's lymphoma; Solid tumours
- Focus Therapeutic Use
- Acronyms MATCH
- 06 Jul 2018 Status changed from not yet recruiting to recruiting.
- 13 Jun 2018 Planned initiation date changed from 22 May 2018 to 22 Aug 2018.
- 23 May 2018 New trial record